Preventive effect of post-ERCP pancreatitis by cooling the duodenal papilla with ice water
Not Applicable
- Conditions
- Gallbladder cancer / bile duct cancer / pancreatic cancer / bile duct stone / cholangitis / pancreatitis / pancreatic cyst / pancreatic duct stenosis / biliary dilatation etc.
- Registration Number
- JPRN-UMIN000034710
- Lead Sponsor
- Kitano Hospital Tazuke Kofukai Medical Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with a history of ERCP Patient in postoperative reconstructed intestinal tract (Except for billroth-I) Patients with acute pancreatitis Patients who require drinking restriction due to heart failure etc. Patients who are judged inappropriate for the research director or the attending physician to conduct this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of post-ERCP pancreatitis
- Secondary Outcome Measures
Name Time Method Patient background (age, sex, past history of pancreatitis, PS, ASA, drinking history, smoking history etc.). Presence or absence of cholangitis before treatment. PEP incidence rate due to differences in ERCP procedures (bile duct obesity, pancreatic ductal purpose, EST, EPBD, biopsy, IDUS, biliary stent, pancreatic duct stent, etc.). PEP incidence rate with or without pancreatic ductal intubation/ ductography. PEP incidence rate due to bile duct intubation time. Increase frequency and degree of pancreatic enzyme and inflammatory reaction (WBC, CRP) after 2 hours of ERCP/ next day in the above items. The degree of PEP in the above items.